These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pancreatitis associated with valproic acid therapy for epilepsy. Coulter DL; Allen RJ Ann Neurol; 1980 Jan; 7(1):92. PubMed ID: 6767434 [No Abstract] [Full Text] [Related]
6. On the toxicity of valproic-acid. Moreiras Plaza M; Rodríguez Goyanes G; Cuiña L; Alonso R Clin Nephrol; 1999 Mar; 51(3):187-9. PubMed ID: 10099893 [TBL] [Abstract][Full Text] [Related]
7. Pancreatitis, complicated by a pancreatic pseudocyst associated with the use of valproic acid. Houben ML; Wilting I; Stroink H; van Dijken PJ Eur J Paediatr Neurol; 2005; 9(2):77-80. PubMed ID: 15843073 [TBL] [Abstract][Full Text] [Related]
8. Acute hemorrhagic pancreatitis due to the use of valproic acid in a child. Ozaydin E; Yükselgüngör H; Köse G Eur J Paediatr Neurol; 2008 Mar; 12(2):141-3. PubMed ID: 17881258 [TBL] [Abstract][Full Text] [Related]
9. [Valproic acid: a simple method for the estimation of free serum concentration]. Parent X; Marzullo C; Gutbub AM Ann Biol Clin (Paris); 1993; 51(6):649-50. PubMed ID: 8172404 [No Abstract] [Full Text] [Related]
10. [Determination of N-Dipropylacetamide serum concentration and its clinical significance in epileptic children]. Shi FL Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Aug; 19(4):217-20. PubMed ID: 3095059 [No Abstract] [Full Text] [Related]
11. The spectrum of valproic acid-associated pancreatitis. Werlin SL; Fish DL Pediatrics; 2006 Oct; 118(4):1660-3. PubMed ID: 17015559 [TBL] [Abstract][Full Text] [Related]
12. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?]. Ettlin T; Scollo-Lavizzari G Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672 [No Abstract] [Full Text] [Related]
13. Pathological case of the month: sudden death in a child as a result of pancreatitis during valproic acid therapy. Mileusnic D; Donoghue ER; Lifschultz BD Pediatr Pathol Mol Med; 2002; 21(5):477-84. PubMed ID: 12396903 [TBL] [Abstract][Full Text] [Related]
14. [Leptilan. Dissolution, bioavailability and first therapeutic results in children with different epilepsy forms]. Windorfer A; Hermannsdörfer-Tröltzsch G; Kienholz M; Maier-Lenz H; Löhr W; Stoll KD Fortschr Med; 1981 Oct; 99(37):1516-22. PubMed ID: 6795098 [No Abstract] [Full Text] [Related]
15. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. Fudio S; Carcas A; Piñana E; Ortega R J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111 [TBL] [Abstract][Full Text] [Related]
16. Acute pancreatitis associated to the use of valproic acid. Guevara-Campos J; González-Guevara L; Vacaro-Bolívar I; Rojas JM Arq Neuropsiquiatr; 2009 Jun; 67(2B):513-5. PubMed ID: 19623456 [No Abstract] [Full Text] [Related]
17. Pancreatic pseudocyst caused by valproic acid: case report and review of the literature. Queizán A; Hernández F; Rivas S Eur J Pediatr Surg; 2003 Feb; 13(1):60-2. PubMed ID: 12664419 [TBL] [Abstract][Full Text] [Related]
18. [Significance of the determination of valproate levels in the blood]. Kuchar M; Smísek M; Cigánek L; Volmut J Cesk Neurol Neurochir; 1987 May; 50(3):203-7. PubMed ID: 3115602 [No Abstract] [Full Text] [Related]
19. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population. Jaffe SL; Sanford M Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962 [No Abstract] [Full Text] [Related]
20. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy. Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255 [No Abstract] [Full Text] [Related] [Next] [New Search]